Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [1] Redistribution of body composition in patients with Graves’ disease after iodine-131 treatment
    L-J Xie
    H-J Zhou
    J-F Li
    F Zhang
    F-W Zeng
    L-P Qin
    Y Chen
    H-J Yuan
    M-H Cheng
    European Journal of Clinical Nutrition, 2015, 69 : 856 - 861
  • [2] The state of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease
    Ahmed, Tania
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S278 - S278
  • [3] Transient hypothyroidism after iodine-131 therapy for Graves' disease
    Gómez, N
    Gómez, JM
    Villabona, C
    Soler, J
    CLINICAL ENDOCRINOLOGY, 1998, 48 (04) : 526 - 527
  • [4] Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease
    Kolade, VO
    Bosinski, TJ
    Ruffy, EL
    PHARMACOTHERAPY, 2005, 25 (07): : 1017 - 1020
  • [5] Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism
    Gómez, JM
    Gómez, N
    Amat, M
    Biondo, S
    Rafecas, A
    Jaurrieta, E
    Soler, J
    ANNALES D ENDOCRINOLOGIE, 2000, 61 (03) : 184 - 191
  • [6] The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: Prevalence, mechanism and prognosis
    Aizawa, Y
    Yoshida, K
    Kaise, N
    Fukazawa, H
    Kiso, Y
    Sayama, N
    Hori, H
    Abe, K
    CLINICAL ENDOCRINOLOGY, 1997, 46 (01) : 1 - 5
  • [7] Predictive factors of repeat therapy in patients receiving iodine-131 for Graves' disease
    Zhang, Ruiguo
    Qin, Lan
    Ren, Zhong
    Wang, Junqi
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [8] The clinical analysis of 50 pregnant women with a history of iodine-131 treatment for Graves' disease
    Guan, Liang
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [9] HYPOPARATHYROIDISM AFTER IODINE-131 TREATMENT OF THYROTOXICOSIS
    ORME, MCL
    CONOLLY, ME
    ANNALS OF INTERNAL MEDICINE, 1971, 75 (01) : 136 - +
  • [10] Iodine-131 therapy alters the immune/inflammatory responses in the thyroids of patients with Graves' disease
    Du, Wenhua
    Dong, Qingyu
    Lu, Xiaoting
    Liu, Xiaomeng
    Wang, Yueli
    Li, Wenxia
    Pan, Zhenyu
    Gong, Qian
    Liang, Cuige
    Gao, Guanqi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 1155 - 1159